6 completed, 2 terminated, 2 unknown, 2 withdrawn. 3 Not applicable, 3 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 4 | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Neutropenia, Febrile: new trials by email Literature Review of Neutropenia, Febrile trials Research Report on Neutropenia, Febrile
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia Comparison short vs extended EBAT treatment group - Neutropenia, Febrile | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 450 | 2024-02-26 | 2026-10-23 |
| Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals. Neutropenia, Neutropenia, Febrile | Unknown | 52 North Health Ltd | 60 | 2023-08-01 | 2023-07-13 | |
| CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients Ceftolozane-tazobactam IV - Neutropenia, Febrile, Hematologic Cancer | Phase 4 | Withdrawn | Hamad Medical Corporation | 2022-08-01 | 2023-08-14 | |
| Remote Monitoring of Patients at Risk of Sepsis Lifetemp/Lifetouch sensors - Neutropenia, Febrile, Cancer | Not applicable | Withdrawn | The Christie NHS Foundation Trust | 2022-03-01 | 2024-12-30 | |
| DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule The Clinical Decision Rule - Neutropenia, Febrile | Not applicable | Terminated | University Hospital, Lille | 63 | 2021-01-27 | 2025-12-11 |
| Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer Early termination of empirical antibiotics - Neutropenia, Febrile, Pediatric Cancer | Not applicable | Completed | Kjeld Schmiegelow | 93 | 2020-11-20 | 2025-04-09 |
| Host RNA Signature in Children With Cancer and Infection RNA expression signature - Childhood Cancer, Infection | Completed | Copenhagen University Hospital, Rigshospitalet | 370 | 2019-06-01 | 2022-12-22 | |
| Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever Ceftazidime Injection, Cefepime Injection - Neutropenia, Febrile, Leukemia | Phase 4 | Completed | Universitas Indonesia | 72 | 2019-03-01 | 2019-12-06 |
| Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit Neutropenia, Febrile | Completed | University Hospital, Brest | 130 | 2017-06-19 | 2024-08-12 | |
| Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study stoppage of antibiotics, amoxycillin/clavulanic acid, levofloxacin - Neutropenia, Febrile, Pediatric Cancer | Phase 3 | Terminated | All India Institute of Medical Sciences | 142 | 2017-01-01 | 2019-02-01 |
| A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever Lipo-AB® (amphotericin B) liposome - Neutropenia, Febrile | Completed | TTY Biopharm | 54 | 2016-05-24 | 2018-04-30 | |
| Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma Diffuse Large B Cell Lymphoma, Neutropenia, Febrile | Unknown | Ajou University School of Medicine | 1000 | 2015-04-01 | 2017-01-26 |
Febrile Neutropenia (12) · Neoplasms (5) · Neutropenia (3) · Infections (2) · Leukemia (2) · Fever (1) · Hematologic Neoplasms (1) · Lymphoma, Large B-Cell, Diffuse (1) · Sepsis (1)
Agranulocytosis (12) · Cytopenia (12) · Hematologic Diseases (12) · Hemic and Lymphatic Diseases (12) · Leukocyte Disorders (12) · Leukopenia (12) · Neutropenia (9) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Pathological Conditions, Signs and Symptoms (2) · Body Temperature Changes (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Inflammation (1)
Amoxicillin-Potassium Clavulanate Combination (1) · Amphotericin B (1) · Cefepime (1) · Ceftazidime (1) · Levofloxacin (1) · Liposomes (1) · ceftolozane, tazobactam drug combination (1)
52 North Health Ltd (1) · Ajou University School of Medicine (1) · All India Institute of Medical Sciences (1) · Copenhagen University Hospital, Rigshospitalet (1) · Hamad Medical Corporation (1) · Kjeld Schmiegelow (1) · TTY Biopharm (1) · The Christie NHS Foundation Trust (1) · Universitaire Ziekenhuizen KU Leuven (1) · Universitas Indonesia (1) · University Hospital, Brest (1) · University Hospital, Lille (1)
Denmark (2) · France (2) · Belgium (1) · India (1) · Indonesia (1) · Qatar (1) · South Korea (1) · Taiwan (1) · United Kingdom (1)
Ali S. Omrani, FRCP (1) · Johan Maertens, MD, PhD (1) · Lotte M. Smedegaard, M.D. (1) · Murti A MD,PhD (1) · Nadja Vissing, MD, PhD (1) · Sameer Bakhshi, Professor (1) · Seong Hyun Jeong, M.D (1) · Yuri Charles Vanbiervliet, MD (1)